Kettering Health is also offering the treatment to eligible patients suffering from moderate symptoms, including fever, cough, chills and shortness of breath.
“This is another tool in our arsenal against COVID-19. By using bamlanivimab, we hope to help more patients avoid hospital stays,” said Jeffrey Weinstein, MD, patient safety officer for Kettering Health Network. “We will continue to seek the latest advancements to ensure that the people of southwest Ohio have access to the best possible care.”
A doctor referral is required to receive the treatment and primary care or emergency room caregivers will determine if the patient qualifies.